Human iPSC-based disease modeling and therapeutic development

iPSC-based therapy for age-related degenerative diseases | Prof Zeng Xian MinПодробнее

Manufacturing GMP-compliant iPSCs in closed and open systems [WEBINAR]Подробнее

iPSC-Derived Brain Cancer Avatars: Lessons Learned and Opportunities for Therapeutic DiscoveryПодробнее

Tools & Strategies for Implementing iPSC-based Cell Models for Neurodegenerative Disease Drug Dis...Подробнее

Heart disease in a dish: Human iPSC-derived multicellular cardiac organoidsПодробнее

3D-cember 2020: AftermovieПодробнее

Engineered iPSC-derived Lymphocytes for Improved Cancer TherapyПодробнее

Harnessing iPSC-derived Cardiac Progenitor Cells and Fibroblasts for Myocardial RepairПодробнее

Development of Therapeutic Approaches for Muscle Disease Using Human Pluripotent Stem CellsПодробнее

Generation of induced pluripotent stem cell-derived cardiomyocytes for disease modelingПодробнее

Improvements in building in vitro pluripotent stem cell-derived disease modelsПодробнее

StemoniX microBrain 3D Assay Ready Plates as a Human iPSC-based Neural Spheroid Platform ...Подробнее

Retinal Pigment Epithelial Cells in Research and Clinical ApplicationsПодробнее

Human iPSC-derived Midbrain Dopaminergic Neurons for Parkinson’s Disease Modeling and Cell TherapyПодробнее

Dr. Birgitt Schuele, ISSCR 2013 -- Generating Parkinson's Disease modelsПодробнее

Human Inducible Pluripotent Stem Cells in Drug Discovery & DevelopmentПодробнее